- Filed
- May 22, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 20, 2024 | 291.46M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $2.84K |
| Operating Cash Flow restated | Q1 2024 · Mar 31, 2024 | −$252.51K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$141.96K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$7.45M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$7.66M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$6.16M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$4.83M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $4.8M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $5.98M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $11.38M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $11.78M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $96.71K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $156.46K |
| Total Assets | Q1 2024 · Mar 31, 2024 | $3.93M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $4.12M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.00 |
| Eps Diluted restated | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.00 |
| Eps Basic restated | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense restated | Q1 2024 · Mar 31, 2024 | $331.04K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $590.94K |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $15.5K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $20.34K |
| Rd Expense | Q1 2024 · Dec 31, 2021 | $284.87K |
| Net Income | Q1 2024 · Mar 31, 2024 | −$292.3K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$2.76M |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$401.56K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$710.63K |
| Revenue | Q1 2024 · Mar 31, 2024 | $52.98K |
| Revenue | Q1 2024 · Mar 31, 2023 | $7.4K |